Low frequency of CHEK2 mutations in familial pancreatic cancer.
Familial pancreatic cancer (FPC) is a rare tumour syndrome and its underlying major gene defect is still unknown. Recently, CHEK2 has been identified as multi-organ cancer susceptibility gene associated with a predisposition to breast, prostate and colon cancer. Since these cancers also are associated with some FPC families, we have analysed 35 index patients of German FPC families for CHEK2 mutations. The CHEK2 * 1100delC mutation was found in 1 (3%) of 35 FPC families. Given the low expected mutation rate of up to 1.4% for CHEK2 * 1100delC in the European population our data are suggestive for possible contribution of CHEK2 mutations to a small subset of FPC.
Bartsch
Detlef K
DK
Department of Surgery, Städtische Kliniken Bielefeld-Mitte, Teutoburgerstrasse 50, D-33604, Bielefeld, Germany. detlef.bartsch@sk-bielefeld.de
Krysewski
Kristina
K
Sina-Frey
Mercedes
M
Fendrich
Volker
V
Rieder
Harald
H
Langer
Peter
P
Kress
Ralf
R
Schneider
Margarete
M
Hahn
Stephan A
SA
Slater
Emily P
EP
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D064447:Checkpoint Kinase 2; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010190:Pancreatic Neoplasms / Q000209:etiology / Q000235:genetics*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*
D064447:Checkpoint Kinase 2; C578634:CHEK2 protein, human; D017346:Protein Serine-Threonine Kinases